Nanosonics Limited Stock Price
- 3 Narratives written by author
- 1 Comments on narratives written by author
- 53 Fair Values set on narratives written by author
NAN Community Narratives
Automated Disinfection Solutions Will Transform Hospital Safety Worldwide
Rising Hospital Cost Containment And Tech Obsolescence Will Erode Profitability
Rising Global Aging And Regulatory Demands Will Accelerate Automated Disinfection
Automated Disinfection Solutions Will Transform Hospital Safety Worldwide
View narrativeRising Hospital Cost Containment And Tech Obsolescence Will Erode Profitability
View narrativeRising Global Aging And Regulatory Demands Will Accelerate Automated Disinfection
View narrativeTrending Discussion
No trending discussion available.
Recently Updated Narratives
NAN: Share Buyback And 2027 Guidance Will Support Future Upside Potential
NAN: Share Buybacks And Lower Profitability Assumptions Will Shape Future Performance
NAN: Lower Discount Rate And Margins Assumed To Support Future Upside
Snowflake Analysis
Nanosonics Limited Key Details
About NAN
- Founded
- 2000
- Employees
- 508
- CEO
- Website
View website
Nanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. It offers trophon, an automated ultrasound probe high-level disinfection device built on hydrogen peroxide chemistry with integrated digital traceability solutions, as well as related consumables and accessories. The company also provides infection control and decontamination products and related technologies. In addition, it is involved in the research, development, and commercialization of the CORIS system, an automated technology designed to transform flexible endoscope reprocessing. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.